Lv51
1105 积分 2021-08-30 加入
In vivo CAR T cell generation to treat cancer and autoimmune disease
2天前
已关闭
Resiquimod‐induced nanovaccine (RINV) for personalized cancer immunotherapy
3天前
已关闭
Next-generation materials for nucleic acid delivery
3天前
已完结
Membrane-IL12 adjuvant mRNA vaccine polarizes pre-effector T cells for optimized tumor control
13天前
已完结
MYO1F in neutrophils is required for the response to immune checkpoint blockade therapy
13天前
已完结
Methotrexate exerts antitumor immune activity and improves the clinical efficacy of immunotherapy in patients with solid tumors
20天前
已完结
Itaconate modulates immune responses via inhibition of peroxiredoxin 5
22天前
已完结
Dynamic DNA-Based Nanoadjuvants for TLR9 Clustering and Innate Immune Activation in Dendritic Cells
1个月前
已完结
Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity
2个月前
已完结
Epo-calypse now
2个月前
已完结
AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylase
皖公网安备34019202002308
